Amgen Inc. buy Truist Financial Co.
Start price
12.04.24
/
50%
€251.00
Target price
12.04.25
€300.61
Performance (%)
23.71%
Price
26.07.24
€308.45
Summary
This prediction is currently active. The prediction currently has a performance of 23.71%. A total of €2.07 was paid as dividends for this prediction. This prediction currently runs until 12.04.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 1.264% | 1.264% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat